The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...

Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising ...

After Novo Nordisk projected yesterday that its revenue could decline by as much as 13% in 2026, its share price has ...

Novartis CEO Vas Narasimhan is doubling down on a growth forecast for 2026, even as the Swiss drugmaker’s fourth-quarter ...

The latest OXB agreement will help advance the company’s CAR-T therapies and provide a “reliable, scalable manufacturing ...

Bristol Myers Squibb has signed Kasey Keller for a partnership around Breyanzi, giving the U.S. | Bristol Myers Squibb has ...

During the first six months of Maziar Mike Doustdar's tenure as Novo Nordisk's CEO, the company enjoyed a run of positive ...

Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said ...

To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. | To stir ...

Miels succeeded Emma Walmsley to become GSK’s new CEO at the beginning of 2026, inheriting the role as GSK posted what he ...

Nanologica, a life sciences company that makes silica-based peptides for the pharmaceutical industry, acquired CDMO Ardena’s Syntagon manufacturing facility in a stock deal valued at 8.6 million ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Leal explained how healthcare and pharma marketing combines the “best of both worlds” for her.